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Salinomycin (SAL), a monocarboxylic polyether antibiotic isolated from Streptomyces albus, modulates
various cellular responses, including proliferation, apoptosis, and inﬂammation. However, the effect of
SAL on the dedifferentiation of chondrocytes remains unclear. Thus, we investigated the effects and
regulatory mechanisms of SAL on the dedifferentiation of rabbit articular chondrocytes. Our results
indicate that SAL-induced a loss of type II collagen and decreased sulfated proteoglycan levels in a dose-
and time-dependent manner, as assessed by western blot analysis and alcian blue staining. Consistent
with dedifferentiation, we found that type II collagen expression was decreased and type I collagen and
SOX-9 expression was increased using RT-PCR. Immunohistochemical and immunoﬂuorescence staining
also indicated dedifferentiation of chondrocytes. SAL treatment activated the mitogen-activated protein
(MAP) kinase signaling pathway. Among the MAP kinases, extracellular signal-regulated kinase (ERK)
was phosphorylated and translocated into the nucleus from the cytosol following SAL treatment. Inhi-
bition of ERK with PD98059 (PD) rescued the SAL-induced decrease in type II collagen, increase in type I
collagen, and reduction in sulfated proteoglycan. Our ﬁndings suggest that SAL induces dedifferentiation
via the ERK pathway in rabbit articular chondrocytes.
© 2014 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Osteoarthritis (OA) is one of the most common chronic diseases
and a major cause of disability among the elderly (1). With an aging
worldwide population, the incidence of OA is rapidly increasing,
and it is anticipated that OAwill become the fourth leading cause of
disability in the coming decades (2). However, despite the growing
number of OA patients, the causes of this disorder have not been
fully elucidated. OA is characterized by progressive degradation of
articular cartilage and insufﬁcient synthesis of cartilage-speciﬁc
ECM because of a loss of chondrocyte phenotype (dedifferentia-
tion), and chondrocyte apoptosis (3). Differentiated chondrocytes,
which are the only cells found in normal mature cartilage, syn-
thesize sufﬁcient amounts of cartilage-speciﬁc extracellular matrix
(ECM) to maintain matrix integrity (1). Further, differentiatedl Sciences, Kongju National
f Korea. Tel.: þ82 (0) 41 850
acological Society.
Production and hosting by Elseviearticular chondrocytes are distinguished by their ability to syn-
thesize cartilage-speciﬁc ECM molecules, type II collagen, and
sulfated-proteoglycan. Dedifferentiation of these chondrocytes re-
sults in loss of type II collagen expression and an increase in type I
and type III collagen. Importantly, modulation of matrix metal-
loproteinases (MMPs) and increased numbers of apoptotic cells are
correlated with the degradation of cartilage matrix (4e6). Thus,
understanding the mechanisms by which ECM synthesis is lost
during OA may be useful for developing novel therapeutics.
Interestingly, previous work has shown that pro-inﬂammatory
cytokines, such as interleukin (IL)-1b and tumor necrosis factor
(TNF)-a, play a crucial role in biochemical alterations of cartilage
and chondrocytes (7). Nitric oxide (NO) produced by IL-1b-stimu-
lated chondrocytes causes dedifferentiation through the activation
and expression of MMPs, thereby inhibiting proteoglycan synthesis
and type II collagen expression. It was further shown that
NO-induced chondrocyte dedifferentiation was regulated by
mitogen-activated protein (MAP) kinases such as extracellular
signal-regulated protein (ERK) and p38 kinase (8,9).
Various stimuli can activate the Raf/MEK/ERK signaling path-
ways, including mitogen and growth factor stimulation (10). Thisr B.V. All rights reserved.
S.-M. Yu, S.-J. Kim / Journal of Pharmacological Sciences 127 (2015) 196e202 197pathway is highly speciﬁc, as Raf can only activate MEK, and MEK
can only activate ERK (11). ERK is primarily localized in the cyto-
plasm of resting cells, and translocates to the nucleus following
acute stimulation (12,13). Thus, it is possible that extracellular
stimulation of the Raf/MEK/ERK could contribute to OA through
chondrocyte dedifferentiation.
Salinomycin (SAL) is a potassium ionophore isolated from
Streptomyces albus that was originally used an antibiotic (14). In
addition to other natural ionophores, it is used commercially as a
coccidiostat in poultry and to promote growth in cattle. Recently, it
was shown that SAL can regulate apoptosis, proliferation, and dif-
ferentiation in diverse cell types (15,16). Not surprisingly, SAL, like
other ionophores, has shown a broad spectrum of bioactivity in a
variety of cancers. However, its effects on chondrocytes remain
unknown. In this study, we evaluated whether SAL could regulate
dedifferentiation in chondrocytes. Our ﬁndings indicate that SAL
promotes the dedifferentiation of chondrocytes through the acti-
vation of ERK kinase.
2. Materials and methods
2.1. Isolation and monolayer culture of rabbit articular
chondrocytes
Rabbit knee articular chondrocytes were isolated from New
Zealand White Rabbits (2-weeks-old, KOATECH, Pyeoungtaek, Re-
public of Korea). The study was approved by the Ethics Committee
at the Kong-ju National University. Cartilage slices were digested
with 0.2% collagenase type II for 7 h in a 37 C CO2 incubator. Pri-
mary cell cultures were seeded at a density of 2 104 cells/dish in a
6-well plate at 37 C, 5% CO2 in DMEMmedium supplemented with
10% fetal bovine serum, penicillin (50 unit/mL), and streptomycin
(50 mg/mL). The medium was replaced every 2 days after seeding.
After 3 days, the cell cultures were treated with salinomycin (SAL;
Sigma, Saint Louis, MO, USA). PD98059 (Calbiochem, San Diego, CA,
USA), which was used to inhibit MEK1/2, was added 1 h prior to
SAL. In some experiments, passage (P) 0 cells were cultured to P2 by
plating cells at a density of 2  104 cells/cm2. The differentiation
status of articular chondrocytes was determined by examining the
expression of type II collagen by western blot analysis, or by
determining the expression of type I collagen by RT-PCR.
2.2. Western blot analysis
Whole cell lysates and chondrocyte nuclear extracts were pre-
pared and subjected to SDS-PAGE. Proteins were extracted using a
buffer containing 50 mM TriseHCl, pH 7.4, 150 mM NaCl, 1% Non-
idet P-40, and 0.1% SDS supplemented with protease inhibitors and
phosphatase inhibitors on ice for 30 min. Cell debris was removed
by centrifugation at 13,000 rpm for 10 min at 4 C. The protein
concentration of the whole cell lysates was determined using a
bicinchoninic acid (BCA) assay. Protein samples were boiled for
5 min in 1  SDS sample buffer (125 mM TriseHCl, pH 6.8, 7.5%
glycerol, 2% SDS, and 0.02% bromophenol blue) containing 1%
mercaptoethanol. Proteins were separated by SDS-PAGE and
transferred to a nitrocellulose membrane. The membrane was
blocked with 5% non-fat dry milk in Tris-buffered saline for 1 h at
room temperature and washed three times with Tween-Tris-buff-
ered saline. The following antibodies were employed to detect
proteins: anti-collagen type II (Santa Cruz, California, CA, USA;
1:1000 dilution), anti-pERK (Cell Signaling Technology, Beverly,
MA, USA; 1:1000 dilution), and anti-glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, Santa Cruz, California, CA, USA; 1:3000
dilution). The membrane was incubated with primary antibodies
overnight at 4 C. The blots were developed using a peroxidase-conjugated secondary antibody (1: 3000 dilution) for 2 h at room
temperature. The enhanced chemiluminescence reagent was used
to identify reactive bands. Finally, the bands were quantiﬁed using
the LAS4000 (Fuji Film, Tokyo, Japan).
2.3. Reverse transcriptase (RT) e PCR
Cells were plated onto 35-mm culture dishes at a density of
2  104. After 3 days, SAL was added to the culture medium and
incubated for 24 h. Cultures were washed with cold PBS, and the
cells were harvested by scraping with a rubber policeman. Cells
cultured without SAL were used as a negative control. Lysates were
microcentrifuged at 13,000 rpm for 10 min at 4 C, and the cell
pellets were collected for mRNA extraction. Total RNA was isolated
with TRIZOL reagent (Invitrogen, Life Technologies, Carlsbad, CA,
USA) according to the manufacturer's instructions. Total RNA
(0.5 mg) was used for cDNA synthesis with the Maxime RT-PCR
PreMix Kit (Intron, Seongnam, Republic of Korea). The following
primers and conditions were used for PCR in rabbit articular
chondrocytes: for type II collagen (370-bp product), 50-GACCC-
CATGCAGTACATGCG-3' (sense) and 50-AGCCGCCATTGATGGTCTCC-
3' (antisense) with an annealing temperature of 52 C; for type I
collagen (441-bp product), 50-GGCTTTCCTGGAGAGAAAGG-3'
(sense) and 50-ATAGAACCAGCAGGGCCAGG-3' (antisense) with an
annealing temperature of 60 C; for SOX-9 (386-bp product), 50-
GCGCGTGCAGCACAAGAAGGACCACCCGGATTACAAGTAC-3' (sense)
and 50-CGAAGGTCTCGATGTTGGAGATGACGTCGCTGCTCAGCTC-3'
(antisense) with an annealing temperature of 60 C; for GAPDH
(299-bp product), 50-TCACCATCTTCCAGGAGCGA-3' (sense) and 50-
CACAATGCCGAAGTGGTCGT-3' (antisense) with an annealing tem-
perature of 50 C. The primers were obtained from Genotech
(Daejeon, Republic of Korea). PCR products were resolved on a 1%
agarose gel and visualized with UV light after ethidium bromide
staining.
2.4. Immunoﬂuorescence staining
Cells were ﬁxed with 3.5% paraformaldehyde in phosphate-
buffered saline (PBS) for 15 min at room temperature and per-
meabilized with 0.1% Triton X-100 in PBS. The cells were then
blocked with 5% skim milk to prevent non-speciﬁc reactions. The
ﬁxed cells were washed and incubated for 2 h with antibodies
against type II collagen (1:100) and pERK. The cells were washed
and incubated with secondary antibodies for 1 h, followed by
washing with PBS. The ﬂuorescence images were recorded with a
BX51 ﬂuorescence microscope (Olympus, Tokyo, Japan).
2.5. Immunohistochemical staining
Rabbit articular cartilage specimens were ﬁxed in 4% formalde-
hyde, embedded in parafﬁn, and cross-sectioned. For immunohis-
tological analysis of type II collagen, sections were deparafﬁnized in
xylene and rehydrated in graded alcohol. After washing with PBS,
the sections were ﬁrst incubated with 3% hydrogen peroxide for
15 min. The sections were immersed in 0.1 M sodium citrate buffer
(pH 7.2) and heated at 90 C in a water bath for 40 min. Next, sec-
tions were blocked with 10% fetal bovine serum for 10 min and
incubated for 1 h at room temperature with a mouse anti-type II
collagen antibody (1:50 dilution) as the primary antibody. The
primary antibody was detected using the avidinebiotin conjugate
method according to the instructions provided in the DAKO kit
(Dako Cytomation, Copenhagen, Denmark). Peroxidase activity was
detected using the DAKO DAB kit (Dako Cytomation). After the
sections were rinsed with PBS, the nuclei were counterstained with
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(100).2.6. Alcian blue staining
The cells were ﬁxed with 3.5% paraformaldehyde in PBS for
15 min and stained with 0.1% Alcian blue in 0.1 M HCl overnight.
The chondrocytes were washed three times with PBS buffer and
6 M guanidine HCl was added for 6 h. Production of sulfated pro-
teoglycan was measured at 595 nm. Rabbit joint cartilage explants
were ﬁxed in 4% paraformaldehyde in PBS for 24 h at 4 C, washed
with PBS, dehydrated with graded ethanol, embedded in parafﬁn,
and sectioned at 4 mm thickness. The sections were stained by
standard procedures using Alcian blue.2.7. MTT assay
Cells were plated onto a 96-well plate and treated with different
concentrations of SAL for 24 h or with 5 mM SAL for the indicated
time periods. The mediumwas removed and cells were cultured in
DMEM supplemented with 0.5 mg/mL MTT. After 4 h incubation,
the insoluble formazan crystals within cells were extracted
by DMSO, and absorbance was measured by ELISA analyzer at
wavelength of 595 nm.Wells without cells were used as blanks andFig. 1. A and B. Primary culture chondrocytes were treated with the indicated concentration
was determined by MTT assay. C. Chondrocytes were treated with 5 mM SAL for 24 hr. Cells
and methods. Data for cell cycle distribution show the percentage of total cells with DNA con
shown are the means ± SEM. *p <0.05 vs. control cells.were subtracted as background from each sample. Results were
expressed as a percentage of control.2.8. Flow cytometry
Chondrocytes were incubated with 5 mM SAL for 24 h. Then cells
were ﬁxed in 70% ethanol at 4 C for 1 h, washed and incubated
with RNAse (50 mg/ml) and propidium iodide (PI, 100 mg/ml) for
30 min at room temperature in the dark. PI ﬂuorescence of nuclei
was measured by ﬂow cytometry on a ﬂow cytometer (Partec
GmbH, Münster, Germany).2.9. Data analysis and statistics
At least three independent experiments were performed in
triplicate for all analyses. Data are presented as the mean ± the
standard error of the mean (SEM). Results were analyzed using a
one-way analysis of variance (ANOVA), and all pairwise compari-
sons between groups were conducted using the Turkey post hoc
test; p values 0.05 were considered statistically signiﬁcant.3. Results
SAL reduces proliferation of rabbit articular chondrocytes.s of SAL for 24 h (A) or with the 5 mM SAL for various time periods (B). Cell proliferation
were analyzed for DNA content by a FACS ﬂow cytometer as described in the materials
tent (G2/M and S phases). The results represent three independent experiments. Values
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treated with the different concentrations of SAL at 1, 2.5, 5, and
10 mM for 24 h or 5 mM SAL for the indicated time periods (Fig. 1).
SAL decreased proliferation of cells in a dose- and time-dependent
manner (Fig. 1A and B).
Fig.1C shows that SAL-induced the percentage of cells at S phase
arrest during cell cycle progression. However, cells at sub-G1 phase
did not alter by SAL. Our results indicated that SAL caused a
decrease of cell proliferation without cell death (Fig. 1). Therefore,
all of the obtained data from alcian blue staining were corrected by
the ratio of proliferation.
SAL causes dedifferentiation of rabbit articular chondrocytes.
To determine whether SAL affects differentiation of chon-
drocytes, we examined type II collagen expression and sulfated-
proteoglycan production after exposure to SAL (Fig. 2). Western
blot analysis revealed that SAL treatment led to a loss of type II
collagen in a dose- and time-dependent manner (Fig. 2, A and B).
RT-PCR analysis revealed that SAL treatment suppressed type II
collagen and Sox-9 expression, and induced ﬁbroblastic type I
collagen expression (Fig. 2, A and B). Interestingly, these pheno-
types are a hallmark of chondrocyte dedifferentiation. We next
examined the synthesis of sulfated-proteoglycans (Fig. 2, C and D).
Alcian blue staining indicated that SAL caused a dose- and time-
dependent decrease in sulfated-proteoglycan synthesis (Fig. 2, C
and D). Since the proliferation of cells were inhibited by SAL in a
dose- and time-dependent manner, the value of Alcian blue stain-
ing was corrected by the ratio of proliferation (Fig. 2C and D). These
results indicate that SAL causes dedifferentiation of chondrocytes
(Fig. 2).
SAL-induced dedifferentiation was regulated by the ERK
pathway.Fig. 2. AeD. Primary cultured chondrocytes were treated with or without the indicated con
(B and D) in rabbit articular chondrocytes. A and B. Expression of type II collagen and GAPDH
II collagen, Sox-9, and GAPDH was detected by RT-PCR (lower panel). GAPDH were used as lo
blue staining. The results represent three independent experiments. Values shown are theWe examined whether SAL-mediated MAPK activation is asso-
ciated with dedifferentiation of chondrocytes (Fig. 3). Western blot
analysis revealed that ERK is phosphorylated in a dose- and time-
dependent manner (Fig. 3A) following SAL treatment. Further,
there is a signiﬁcant increased immunoreactivity of pERK (Fig. 3B).
Interestingly SAL-induced ERK phosphorylation (Fig. 3A) and pERK
nuclear translocation reached a maximum after 24 h. Further, there
was no change in total ERK level was observed. These data suggest
that SAL caused the phosphorylation of ERK and translocation of
ERK into the nucleus (Fig. 3).
To examine whether ERK plays a crucial role in the regulation of
type II collagen, we treated cells with or without the speciﬁc in-
hibitor PD98059 (Fig. 4). Treatment with PD98059 reversed the
SAL-induced loss of type II collagen and Sox-9, and reduced the
SAL-induced increase in type I collagen, as determined by RT-PCR
(Fig. 4A). Western blot analysis also revealed that treatment of
cells with PD98059 and SAL recovered the type II collagen
expression (Fig. 4B). Alcian blue staining showed that SAL signiﬁ-
cantly reduced sulfated-proteoglycans, an effect that was
completely blocked by PD98059 treatment (Fig. 4C). Treatment of
chondrocytes with PD98059 did not alter cell proliferation and
apoptosis (Fig. 4D). These results support the notion that ERK
activation is sufﬁcient to cause the dedifferentiation of chon-
drocytes in response to SAL (Fig. 4).
The effect of PD98059 on type II collagen expression and
sulfated-proteoglycan production in chondrocytes and cartilage
was further evaluated using immunoﬂuorescence and immuno-
histochemical microscopy (Fig. 5). Double staining for type II
collagen and the nucleus showed that treatment with SAL resulted
in a loss of type II collagen and sulfated-proteoglycan staining. In
contrast, PD98059 treatment reversed the SAL-induced suppressioncentrations of SAL for 24 h (A and C) or with 5 mM SAL for the speciﬁed time periods
was analyzed by western blot analysis (upper panel). Expression of type I collagen, type
ading controls. C and D. The synthesis of sulfated-proteoglycan was detected via Alcian
means ± SEM. *p <0.05 vs. control cells.
Fig. 3. A. Chondrocytes were treated with or without the indicated concentrations of SAL for 24 h or 5 mM SAL for the speciﬁed time periods in rabbit articular chondrocytes. The
expression of pERK and GAPDH were analyzed by western blot analysis. ERK was used as a loading control. B. Expression of ERK was determined by immunoﬂuorescence staining.
The nucleus of cells were stained with 40-6-diamidino-2-phenylindole (DAPI). The results represent three independent experiments.
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(Fig. 5). Thus, these results indicate that SAL induces chondrocytes
dedifferentiation through the ERK pathway (Fig. 5).
Chondrocytes can undergo dedifferentiation upon serial
monolayer culture, and display a loss of type II collagen expression
and enhanced type I collagen expression. This effect can be
reversed by culturing dedifferentiated cells in alginate gel (17).
Dedifferentiation caused by serial monolayer culture at P2 signiﬁ-
cantly enhanced ERK-1/2 activity, and the addition of PD98059
decreased phosphorylation levels (Fig. 6). Treatment of dediffer-
entiated cells with SAL resulted in an accelerated decrease in type II
collagen expression as detected by western blot analysis (Fig. 6).
Under these conditions, RT-PCR also revealed that treatment with
PD98059 inhibited SAL-induced dedifferentiation, conﬁrming a
loss of type I collagen and an increase in type II collagen expression
(Fig. 6).
SAL enhances MMP-1 and MMP-13 expression independent of
the ERK pathway.
MMPs suppress the expression of cartilage-speciﬁc ECM com-
ponents, such as type II collagen and prostaglandins. We therefore
examined the expression of MMPs (MMP-1 and MMP-13) to assess
whether they are related to SAL-induced dedifferentiation (Fig. 7).
SAL treatment increasedMMP-1 andMMP-13 expression in a dose-Fig. 4. AeC. Rabbit chondrocytes were treated with or without 5 mM SAL for 24 h in the prese
collagen, type II collagen, Sox-9, and GAPDH was determined by RT-PCR. GAPDH was used as
by western blot analysis. GAPDH was used as a loading control. C. The synthesis of sulfated-p
the various concentrations of PD for 24 h. The results represent three independent experimdependent manner (Fig. 7A); however, treatment with PD98059
did not have an effect on SAL-induced MMP-1 and MMP-13
expression (Fig. 7B). These data indicate that SAL regulates MMPs
(MMP-1 and MMP-13) independent of the ERK signaling pathway.4. Discussion
SAL is widely used in veterinary medicine and has recently been
shown to regulate cellular responses in various cell types (18). The
pharmacological action of SAL has generated increased attention in
recent years. Recent studies have demonstrated that SAL is toxic to
cancer stem cells, through its ability to deplete cellular ATP.
Nevertheless, SAL is relatively non-toxic in primary cells (19). The
anticancer activity of SAL is related to oxidative stress, through the
production of endogenous reactive oxygen species (ROS) that can
disrupt mitochondrial function (20, 21). In our previous studies,
stress agents, such as ROS, were shown to regulate apoptosis,
proliferation, differentiation, and inﬂammation in rabbit articular
chondrocytes (22). Furthermore, Szkudlarek-Mikyo et al., reported
that SAL regulates differentiation in adipocytes (18). However,
there is a lack of data regarding the potential effects of SAL on
differentiation.nce or absence of the indicated concentrations of PD98059 (PD). A. Expression of type I
a loading control. B. Expression of type II collagen, pERK, ERK, and GAPDH was analyzed
roteoglycans was detected by Alcian blue staining. D. Cells were treated with or without
ents. Values shown are the means ± SEM. *p <0.05 vs. control cells.
Fig. 5. Rabbit cartilage or chondrocytes were treated with or without 5 mM SAL for 24 or 48 h in the presence or absence of the indicated concentrations of PD98059 (PD).
Expression of type II collagen was detected by immunoﬂuorescence staining and immunohistochemical staining. The production of sulfated-proteoglycan was detected by alcian
blue staining. The data show the results of a typical experiment from three independent experiments.
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chondrocyte dedifferentiation. We found that SAL could induce
dedifferentiation in vitro. SAL treatment was shown to affect the
expression of several proteins including Sox-9. Previous studies
have shown that Sox-9 has a primary role in chondrocyte differ-
entiation. Sox-9 plays a crucial role in the speciﬁc activation of
collagen type II, and is a key transcriptional regulator of chon-
drocytes differentiation (23,24). Furthermore, SAL treatment
decreased the intensity of Alcian blue staining, suggesting a
decrease in the synthesis of sulfated-proteoglycan (Fig. 2). Strik-
ingly, however, SAL did not affect the production of intracellular
ROS in chondrocytes.
Numerous signaling pathways contribute to chondrocytes
dedifferentiation, including the MAPK pathway. Previous reportsFig. 6. Chondrocytes were serially sub-cultured to P2, and the expression of type II
collagen, pERK, ERK, and GAPDH was determined by Western blot analysis. The mRNA
levels of type I collagen, type II collagen, and GAPDH were detected by RT-PCR. The
data shows the results of a typical experiment from three independent experiments.indicate that the ERK pathway mediates chondrocytes dedifferen-
tiation in rabbit chondrocytes (25,26). In addition, p38 and JNK are
known to control cell proliferation, inﬂammation, and differentia-
tion (10,23,25,27,28). Several dedifferentiation stimulating factors,
such as SNP and RA, have been used to show that the activation of
MAPK is needed to cause chondrocytes dedifferentiation (29e31).
To investigate the involvement of the MAPK cascade during SAL-
induced dedifferentiation of chondrocytes, the phosphorylation
pattern of the three major pathways that involve MAPK family
members, ERK, p38, and JNK, were assessed by western blot after
SAL treatment. Chondrocytes treated with SAL displayed enhanced
ERK kinase activity, without alterations to JNK and p38MAP kinase,
suggesting that SAL can induce dedifferentiation of chondrocytes
via the ERK signaling pathways.Fig. 7. A. Primary cultured chondrocytes were treated with or without the indicated
concentrations of SAL for 24 h. A. The expression of MMP-1, MMP-13, and GAPDH was
analyzed by western blot analysis. GAPDH was used as a loading control. B. Rabbit
chondrocytes were treated with or without 5 mM SAL for 24 h in the presence or
absence of the indicated concentrations of PD98059 (PD). Expression of type II
collagen, MMP-1, MMP-13, and GAPDH was analyzed by western blot analysis. GAPDH
was used as a loading control. The results represent three independent experiments.
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erated collagen produced by native collagen type I, II, IV, and VX
after cleavage by collagenase, aggrecan, elastin, and ﬁbronectin
(5,32). MMP has been shown to play a signiﬁcant role in chon-
drocytes dedifferentiation. In OA, chondrocytes produce abnor-
mally high levels of interstitial collagenases (MMP-1 and MMP-13),
a member of the Zn2þ- and Ca2þ-dependent family of matrix
metalloproteinases (4,5). In the present study, SAL-induced MMP-1
and MMP-13 expression (Fig. 7). However, PD98059, a selective
inhibitor of ERK, had no effect on SAL-inducedMMP-1 andMMP-13
expression. This data collectively suggest that the ERK cascade does
not play a pivotal role in the expression of MMP-1 and MMP-13 in
SAL-induced dedifferentiation.
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